AGMB
AgomAb Therapeutics NV
NASDAQ · Healthcare · Biotechnology · BE
$12.17
+0.75%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.99x
- Price / sales
- —
- Price / cash flow
- -10.09x
Enterprise value
- Enterprise value
- $467.0M
- EV / sales
- —
- EV / EBITDA
- -6.53x
- EV / EBIT
- -6.86x
- Market cap
- $599.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025